Free Trial

Ocular Therapeutix (OCUL) SEC Filings & 10K Form

Ocular Therapeutix logo
$8.83 +0.31 (+3.64%)
(As of 11/22/2024 ET)

Recent Ocular Therapeutix SEC Filings

DateFilerForm TypeView
11/14/2024
4:49 PM
Ocular Therapeutix (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
8:37 AM
Avoro Capital Advisors LLC (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G
11/14/2024
6:30 AM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2024
6:10 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:15 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
3:49 PM
Ocular Therapeutix (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G/A
10/16/2024
3:25 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
4:31 PM
Anderman Todd (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
4:32 PM
Anderman Todd (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:20 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:17 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
4:18 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
4:20 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:21 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:01 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
4:17 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:19 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:18 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
4:10 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:36 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
4:32 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:15 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
6:23 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:13 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:30 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
6:30 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:38 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:39 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
RAINES MERILEE (Reporting)
RAINES MERILEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:41 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:19 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:22 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:53 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:20 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:23 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
8:03 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
4:26 PM
Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2024
4:28 PM
Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

06/03/2024
8:15 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
4:17 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
3:33 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
3:16 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
3:18 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
3:20 PM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:22 PM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/29/2024
3:19 PM
Ocular Therapeutix (Filer)
Form ARS
03/29/2024
4:11 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
3:23 PM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
3:43 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
7:02 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:04 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:06 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
7:07 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:00 AM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:34 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:48 PM
Ocular Therapeutix (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G/A
02/06/2024
5:35 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:38 PM
Ocular Therapeutix (Issuer)
White Christopher G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:26 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:29 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:32 PM
Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:41 PM
Ocular Therapeutix (Subject)
White Christopher G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:33 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:36 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:39 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
6:00 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:01 PM
Ocular Therapeutix (Issuer)
White Christopher G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:01 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:02 PM
Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:03 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:34 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:36 PM
Ocular Therapeutix (Subject)
White Christopher G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:39 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:41 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:31 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G/A
01/25/2024
7:04 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:17 PM
Ocular Therapeutix (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
12/22/2023
3:04 PM
Deep Track Capital, LP (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G
12/18/2023
3:52 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:52 PM
Ocular Therapeutix (Subject)
SUMMER ROAD LLC (Filed by)
Form SC 13D/A
12/14/2023
3:09 PM
Ocular Therapeutix (Filer)
Form 424B5
12/14/2023
7:46 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OCUL) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners